1-7 of 7
Kevin M. Koch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I and Pharmacokinetic Study of Oral Lapatinib Administered Once or Twice Daily in Patients with Solid Malignancies

Howard A. Burris, III, Charles W. Taylor, Suzanne F. Jones, Kevin M. Koch, Melissa J. Versola, Niki Arya, Ronald A. Fleming, Deborah A. Smith, Lini Pandite, Neil Spector, George Wilding
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (21): 6702–6708.
https://doi.org/10.1158/1078-0432.CCR-09-0369
Published: 02 November 2009
View article titled, A Phase I and Pharmacokinetic Study of Oral Lapatinib Administered Once or Twice Daily in Patients with Solid Malignancies
Open the PDF for A Phase I and Pharmacokinetic Study of Oral Lapatinib Administered Once or Twice Daily in Patients with Solid Malignancies in another window
Journal Articles

A Phase I Study of a 2-Day Lapatinib Chemosensitization Pulse Preceding Nanoparticle Albumin-Bound Paclitaxel for Advanced Solid Malignancies

Amy J. Chien, Julie A. Illi, Andrew H. Ko, Wolfgang M. Korn, Lawrence Fong, Lee-may Chen, Mohammed Kashani-Sabet, Charles J. Ryan, Jonathan E. Rosenberg, Sarita Dubey, Eric J. Small, Thierry M. Jahan, Nola M. Hylton, Benjamin M. Yeh, Yong Huang, Kevin M. Koch, Mark M. Moasser
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (17): 5569–5575.
https://doi.org/10.1158/1078-0432.CCR-09-0522
Published: 31 August 2009
View article titled, A Phase I Study of a 2-Day Lapatinib Chemosensitization Pulse Preceding Nanoparticle Albumin-Bound Paclitaxel for Advanced Solid Malignancies
Open the PDF for A Phase I Study of a 2-Day Lapatinib Chemosensitization Pulse Preceding Nanoparticle Albumin-Bound Paclitaxel for Advanced Solid Malignancies in another window
Journal Articles

Evaluation of Lapatinib and Topotecan Combination Therapy: Tissue Culture, Murine Xenograft, and Phase I Clinical Trial Data

Julian R. Molina, Scott H. Kaufmann, Joel M. Reid, Stephen D. Rubin, Marina Gálvez-Peralta, Robert Friedman, Karen S. Flatten, Kevin M. Koch, Tona M. Gilmer, Robert J. Mullin, Roxanne C. Jewell, Sara J. Felten, Sumithra Mandrekar, Alex A. Adjei, Charles Erlichman
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (23): 7900–7908.
https://doi.org/10.1158/1078-0432.CCR-08-0415
Published: 01 December 2008
View article titled, Evaluation of Lapatinib and Topotecan Combination Therapy: Tissue Culture, Murine Xenograft, and Phase I Clinical Trial Data
Open the PDF for Evaluation of Lapatinib and Topotecan Combination Therapy: Tissue Culture, Murine Xenograft, and Phase I Clinical Trial Data in another window
Includes: Supplementary data
Journal Articles

A Phase I and Pharmacokinetic Study of Lapatinib in Combination with Letrozole in Patients with Advanced Cancer

Quincy S.C. Chu, Mary E. Cianfrocca, Lori J. Goldstein, Meg Gale, Nicholas Murray, Jill Loftiss, Nikita Arya, Kevin M. Koch, Lini Pandite, Ronald A. Fleming, Elaine Paul, Eric K. Rowinsky
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (14): 4484–4490.
https://doi.org/10.1158/1078-0432.CCR-07-4417
Published: 15 July 2008
View article titled, A Phase I and Pharmacokinetic Study of Lapatinib in Combination with Letrozole in Patients with Advanced Cancer
Open the PDF for A Phase I and Pharmacokinetic Study of Lapatinib in Combination with Letrozole in Patients with Advanced Cancer in another window
Journal Articles

A Dose-Escalation Study of Recombinant Human Interleukin-18 Using Two Different Schedules of Administration in Patients with Cancer

Michael J. Robertson, John M. Kirkwood, Theodore F. Logan, Kevin M. Koch, Steven Kathman, Lyndon C. Kirby, William N. Bell, Linda M. Thurmond, Jill Weisenbach, Mohammed M. Dar
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (11): 3462–3469.
https://doi.org/10.1158/1078-0432.CCR-07-4740
Published: 02 June 2008
View article titled, A Dose-Escalation Study of Recombinant Human Interleukin-18 Using Two Different Schedules of Administration in Patients with Cancer
Open the PDF for A Dose-Escalation Study of Recombinant Human Interleukin-18 Using Two Different Schedules of Administration in Patients with Cancer in another window
Journal Articles

Phase I Pharmacokinetic Study of the Safety and Tolerability of Lapatinib (GW572016) in Combination with Oxaliplatin/Fluorouracil/Leucovorin (FOLFOX4) in Patients with Solid Tumors

Wandena S. Siegel-Lakhai, Jos H. Beijnen, Walter L. Vervenne, Henk Boot, Marianne Keessen, Melissa Versola, Kevin M. Koch, Deborah A. Smith, Lini Pandite, Dirk J. Richel, Jan H.M. Schellens
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4495–4502.
https://doi.org/10.1158/1078-0432.CCR-07-0004
Published: 01 August 2007
View article titled, Phase I Pharmacokinetic Study of the Safety and Tolerability of Lapatinib (GW572016) in Combination with Oxaliplatin/Fluorouracil/Leucovorin (FOLFOX4) in Patients with Solid Tumors
Open the PDF for Phase I Pharmacokinetic Study of the Safety and Tolerability of Lapatinib (GW572016) in Combination with Oxaliplatin/Fluorouracil/Leucovorin (FOLFOX4) in Patients with Solid Tumors in another window
Journal Articles

Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer

Michael J. Robertson, James W. Mier, Theodore Logan, Michael Atkins, Henry Koon, Kevin M. Koch, Steven Kathman, Lini N. Pandite, Coreen Oei, Lyndon C. Kirby, Roxanne C. Jewell, William N. Bell, Linda M. Thurmond, Jill Weisenbach, Suzanne Roberts, Mohammed M. Dar
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4265–4273.
https://doi.org/10.1158/1078-0432.CCR-06-0121
Published: 20 July 2006
View article titled, Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer
Open the PDF for Clinical and Biological Effects of Recombinant Human Interleukin-18 Administered by Intravenous Infusion to Patients with Advanced Cancer in another window